Sep 2 2010
TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several different methods, including stem cell therapy and tissue engineering.
Before scientific advances such as stem cells, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not) or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remedy countless physical maladies that have afflicted humans and other animals through techniques like stem cells and tissue engineering.
In this study, TriMark Publications reviews the market for regenerative medicine solutions. The areas covered in this study include: available and emerging technologies in the field, the U.S. and global market size for regenerative medicine products, and profiles of companies that are focusing on the regenerative medicine sector.
Reasons to Buy TriMark Content
- Data is updated regularly in accordance with changes in the industries our reports cover.
- Information is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.
- Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors companies focused on biotechnology, life sciences, healthcare, pharmaceuticals and medical devices operate in.
- Your competitors are buying TriMark content!
SOURCE TriMark Publications, LLC
Renaissance of "food as medicine" in modern clinical trials